期刊文献+

大疱性类天疱疮皮损中Th1/Th2趋化因子及其受体的表达 被引量:10

Expression of Th1/Th2 chemokines and their receptors in the lesions of bullous pemphigoid
暂未订购
导出
摘要 目的:研究Th1趋化因子CXCL9/MIG、CXCL10/IP-10、CXCL11/I-TAC和Th2型趋化因子CCL22/MDC及其受体CXCR3、CCR4在大疱性类天疱疮(BP)皮损中的表达。方法:应用免疫组化方法检测30例BP患者皮损及20例正常皮肤中CX-CL9、CXCL10、CXCL11、CCL22、CXCR3和CCR4的表达。结果:BP皮损中4种趋化因子及其受体的表达均高于正常皮肤。其中,Th1趋化因子CXCL9、CXCL10和CXCL11及其受体CXCR3的阳性率分别为50%(15/30)、46.7%(14/30)、46.7%(14/30)和53.3%(16/30),Th2趋化因子CCL22及其受体CCR4的阳性率分别为66.7%(20/30)、56.7%(17/30)。正常对照中CXCL9、CX-CL10、CXCL11及其受体CXCR3的阳性率分别为10.0%(2/20)、10.0%(2/20)、15.0%(3/20)和15.0%(3/20),CCL22及其受体CCR4的阳性率分别为20.0%(4/20)和25.0%(5/20)。结论:Th1趋化因子CXCL9、CXCL10、CXCL11和Th2趋化因子CCL22及其受体CXCR3和CCR4在BP皮损中表达升高,提示它们可能在BP的发病机制中起一定作用。 Objective: To investigate the expression of Thl chemokine CXCL9, CXCL10, CXCL11, Th2 chemokine CCL22 and their receptors in the lesions of bullous pemphigoid (BP). Methods: Imrnunohistochemical assay was performed to detect the expression of CXCL9, CX- CL10,CXCLll,CCL22 and their receptors CXCR3 and CCR4 in BP lesions and normal control skin. Results: CXCL9, CXCL10, CXCLll, CCL22, CXCR3 and CCR4 were overexpressed in BP lesions than those in normal control skin ( P 〈 0.01 ). The positive rates of CXCL9, CX- CL10, CXCL11 and CXCR3 in BP lesions were 50 % ( 15/30 ), 46.7 % ( 14/30 ), 46.7 % (14/30) and 53.3 % (16/30), respectively. The positive rates of CCL22 and CCR4 were 66.7% (20/30) and 56.7% (17/30). Conclusion: The overexpression of Thl chemokine CXCIB, CX-CL10, CXCL11, Th2 chemokine CCL22 and their receptors may play important roles in the pathogenesis of BP.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2010年第3期270-272,共3页 Chinese Journal of Immunology
基金 国家自然科学基金(30400389) 教育部高等学校博士学科点专项科研基金(20060159014) 教育部创新团队(IRT0760) 辽宁省创新团队(2008T192)资助
关键词 大疱性类天疱疮 CXCL9 CXCL10 CXCL11 CCL22 CXCR3 CCR4 Bullous Pemphigoid CXCL9 CXCL10 CXCL11 CCL22 CXCR3 CCR4
  • 相关文献

参考文献10

  • 1Kakinuma T, Wakugawa M, Nakamura K et al. High level of thymus and activation-regulatedchemokine in blister fluid and sera of patients with bullous pemphigoid[J]. Br J Dermatol,2003; 148(2) :203-210.
  • 2Flier J, Boorsnm D M, Bruyrmeel D Pet al. The CXCR3 activating chemokines IP-10, Mig and IP-9 are expressed in allergic but not in irritant patch test reactions [ J ]. J Invest Dermatol, 1999 ; 113 (4) : 574-578.
  • 3刘伦飞,郑敏.CXCR3及其配体与皮肤病[J].国外医学(皮肤性病学分册),2002,28(3):166-169. 被引量:4
  • 4Ono S J, Nakamura T, Miyazaki D et al. Chemokines: roles in leukocyte development, trafficking, and effector function[J]. J Allergy Clin Immunol, 2003 ; 111 (6) : 1185-1199.
  • 5Ruehhnmm J M, Xiang R, Niethammer A Get al. Mig/CXCL9 chemokine gene therapy combines with antibody eytokine fusion protein to suppress growth and dissemination of murine colon carcinoma[J].Cancer Research, 2001 ;61(23) :8498-8503.
  • 6李群,谭锦泉,黄保军,胡春松,陈静,PerS.Skov,LarsK.Poulsen,罗畅民.γIP-10和Mig通过趋化因子CXC受体3激活嗜酸性粒细胞的NFAT[J].中华微生物学和免疫学杂志,2001,21(5):510-515. 被引量:1
  • 7刘海娜,吴春玲,蒋莉,张晓莉,李舒帆,王晓非.系统性红斑狼疮患者血浆巨噬细胞衍生趋化因子水平及临床意义[J].中华风湿病学杂志,2005,9(3):142-144. 被引量:8
  • 8Horikawa T, Nakaymna T, Hikita I et al. IFN-gamma-inducible expression of thymus and activation-regulated chemokine/CCL17 and macrophage-derived chemokine/ CCL22 in epidermal keratinocytes and their roles in atopic dermatitis [ J ]. hat Immunol, 2002 ; 14 (7) : 767-773.
  • 9Hashimoto S, Nakamura K, Oyama N et al. Macrophage-derived chemokine (MDC)/CCL22 produced by monocyte derived dendritic cells reflects the disease activity in patients with atopic dermatitis[ J ]. J Dermatol Sci, 2006; 44(2) :93-99.
  • 10Xiao T, Fujita H, Saeki H et al. Thymus and activation-regulated chemokine(TARC/CCLl7) prcduced by mouse epidermal Langerhans cells is upregulated by TNF-alpha and IL-4 and downregulated by IFN- gamma [ J ]. Cytokine, 2003 ; 23 ( 4-5 ) :126-132.

二级参考文献42

  • 1Jinquan T,J Immunol,1999年,163卷,21页
  • 2Jinquan T,J Immunol,1999年,162卷,4285页
  • 3Weng Y,J Biol Chem,1998年,273卷,18288页
  • 4Qin S,J Clin Invest,1998年,101卷,746页
  • 5Soto H,Proc Nat Acad Sci USA,1998年,95卷,8205页
  • 6Rao A,Annu Rev Immunol,1997年,15卷,707页
  • 7Ohkawara Y,J Clin Invest,1996年,97卷,1761页
  • 8Takanaski S,J Exp Med,1994年,180卷,711页
  • 9Funauchi M, Ikoma S, Enomoto H, et al. Decreased Th1-like and increased Th2-1ike cells in systemic lupus erythematosus. Scand J Rheumatol, 1998, 27: 19-24.
  • 10Akahoshi M, Nakashima H, Tgoaka Y, et al. Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus.Arthritis Rheum, 1999, 42: 1644-1648.

共引文献10

同被引文献108

  • 1刘智,阙国鹰,李金焕,邓金霞,李露璐,刘婷婷,苏达.儿童龋病与唾液CCL28和sIgA抗体的相关性[J].中南大学学报(医学版),2015,40(1):102-106. 被引量:6
  • 2周健光,郑敏.TARC在某些皮肤疾病的研究进展[J].国外医学(皮肤性病学分册),2005,31(1):30-32. 被引量:2
  • 3Zlotnik A,Yoshie O.Chemokines:a new classification system and their role in immunity[J].Immunity,2000,12:121-127.
  • 4Moster B,Loetscher P.Lymphocyte traffic control by chemokines[J].Nat Immunol,2001,2:123-128.
  • 5Martí RM,Estrach T,Reverter JC,et al.Prognostic clinicopathologic factors in T-cell lymphoma[J].Arch Dermatol,1991,127:1511-1516.
  • 6Saeki H,Tamaki K.Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases[J].J Dermatol Sci,2006,43:75-84.
  • 7Sallusto F,Lenig D,Mackay CR,et el.Flexible programs of chemokine receptors expression on human polarized T helper 1 and 2lymphocytes[J].J Exp Med,1998,187:875-883.
  • 8Nakashima H,Fujimoto M,Asashima N,et el.Serum chemokine profile in patients with bullous pemphigoid[J].Br J Dermatol,2007,156:454-459.
  • 9Echigo T,Hasegawa M,Shimada Y,et al.Both Th1 and Th2 chemokines are elevated in sera of patients with autoimmune blistering diseases[J].Arch Dermatol Res,2006,298:38-45.
  • 10Park MK,Amichay D,Love P,et al.The CXC chemokine murine monokine induced by IFN-gamma (CXC chemokine ligand 9) is made by APCs,targets lymphocytes including activated B cells,and supports antibody responses to a bacterial pathogen in vivo[J].J Immunol,2002,169:1433-1443.

引证文献10

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部